For cancer signaling, MTORC1 and PI3K-AKT-MTOR pathway were significantly enriched in the high-m7Gscore group, while KRAS and hypoxia pathways were enriched in the low-m7Gscore group. This evidence concerns the gene AKT1 and cancer.